-
J&J CEO Alex Gorsky leaves Trump council as president breaks it up
fiercepharma
August 17, 2017
Johnson & Johnson CEO Alex Gorsky said on Wednesday he was leaving President Donald Trump's manufacturing council, just as the president said he's putting an end to the group.
-
Cerecor CEO retires after scoring Johnson & Johnson license deal
fiercebiotech
August 16, 2017
J&J is paying $25 million upfront for rights to CERC-501.
-
Johnson & Johnson expected to keep battling talc claims despite losses: expert
fiercepharma
August 14, 2017
Johnson & Johnson faces 4,800 cases alleging harm from talc use, according to the drugmaker's recent quarterly filing.
-
A Review of the Biggest Big Pharmas, New and Old
fiercepharma
August 11, 2017
From perennial giants Johnson & Johnson, Pfizer and Novartis to the buyout targets to the newest names at the top of revenue rankings of pharmaceautical industry, the numbers tell only part of the truths.
-
Johnson & Johnson Announced first-in-human clinical data for investigational HIV preventive vaccine
worldpharmanews
July 27, 2017
Johnson & Johnson announces encouraging first-in-human clinical data for investigational HIV preventive vaccine
-
Financial Report: Johnson & Johnson
contractpharma
July 27, 2017
Worldwide Pharmaceutical sales were flat at $8.6 billion in the quarter. Domestic sales were down 3%; international sales increased 3%, which reflected an operational increase of 6% and a negative currency impact of 3%. Remicade sales were down 14% to $1.
-
How did Johnson & Johnson beat back Remicade's biosim? Call it the art of the deal
fiercepharma
July 21, 2017
Johnson & Johnson has been surprisingly successful at fending off Pfizer's Remicade biosimilar, and that didn't happen by accident. The pharma giant's upfront dealmaking and money-off pricing did the job.
-
Johnson & Johnson launches skincare range Aveeno in India
financialexpress
July 14, 2017
Aveeno Baby launch to be followed by Aveeno Body later this year
-
Johnson & Johnson launches skincare range Aveeno in India
expressbpd
July 13, 2017
Aveeno Baby launch to be followed by Aveeno Body later this year
-
Johnson & Johnson face major lawsuit over vaginal mesh
pharmafile
July 05, 2017
Johnson & Johnson will face a lawsuit after 700 Australian women launched a class action suit over the failures of its vaginal mesh implant.